Zinzani PL, Mayer J, Flowers CR, Bijou F, et al. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. J Clin Oncol 2023 Jul 28:101200JCO2300775. doi: 10.1200/JCO.23.00775.
PMID: 37506346